Short answer
STANDARD BIOTOOLS INC. (LAB) filed an 8-K current report with the SEC on May 28, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). New severance coverage through August 4, 2028 for CFO Alex Kim and CBO Sean Mackay.
STANDARD BIOTOOLS INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- New severance coverage through August 4, 2028 for CFO Alex Kim and CBO Sean Mackay
- Non-change-of-control termination benefits: 100% of salary over 12 months plus prorated target bonus and 12 months’ healthcare
- Change-of-control termination benefits: 150% of salary plus bonus, prorated bonus, 18 months’ healthcare, and full equity vesting
- CEO Michael Egholm receives richer protection: 200% salary over 24 months outside a change of control
- CEO change-of-control protection totals 250% of salary plus bonus, 30 months’ healthcare, and full equity vesting
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other STANDARD BIOTOOLS INC. 8-K filings
Get the next LAB 8-K as it lands
Follow LAB for push alerts, or ask the research agent what this filing means.